SEOUL -- Macrogen, a biotech company headquartered in Seoul, has established a local subsidiary in Singapore to focus on the rapidly growing Southeast Asian market.
Macrogen said in a statement on Tuesday that the company established "Macrogen Asia Pacific" in Singapore's biomedical complex that would become a base to expand its business in Southeast Asia's genome sequencing and analysis market.
"Macrogen will operate the Singapore genome center as a strategic position for expanding into Southeast Asia's genome sequencing and analysis market in earnest," President Moon Ji-young said in the statement. Macrogen's R&D center will participate in projects with national research institutes and hospitals.
See URL for details : http://www.ajudaily.com/view/20180605092610256
Source : Ajudaily